Literature DB >> 27396526

Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity.

Abigail E Russi1, Margaret E Walker-Caulfield2, Yong Guo2, Claudia F Lucchinetti2, Melissa A Brown3.   

Abstract

GM-CSF is a cytokine produced by T helper (Th) cells that plays an essential role in orchestrating neuroinflammation in experimental autoimmune encephalomyelitis, a rodent model of multiple sclerosis. Yet where and how Th cells acquire GM-CSF expression is unknown. In this study we identify mast cells in the meninges, tripartite tissues surrounding the brain and spinal cord, as important contributors to antigen-specific Th cell accumulation and GM-CSF expression. In the absence of mast cells, Th cells do not accumulate in the meninges nor produce GM-CSF. Mast cell-T cell co-culture experiments and selective mast cell reconstitution of the meninges of mast cell-deficient mice reveal that resident meningeal mast cells are an early source of caspase-1-dependent IL-1β that licenses Th cells to produce GM-CSF and become encephalitogenic. We also provide evidence of mast cell-T cell co-localization in the meninges and CNS of recently diagnosed acute MS patients indicating similar interactions may occur in human demyelinating disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caspase-1; Experimental autoimmune encephalomyelitis (EAE); GM-CSF; IL-1beta; Inflammasome; Mast cells; Meninges; Multiple sclerosis (MS); Myeloid cells; T cell licensing; T helper cells

Mesh:

Substances:

Year:  2016        PMID: 27396526      PMCID: PMC6364701          DOI: 10.1016/j.jaut.2016.06.015

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  18 in total

Review 1.  An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses.

Authors:  Melissa A Brown; Maureen A Su
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

2.  (T)Betting on innate lymphoid cells in CNS inflammatory disease.

Authors:  Melissa A Brown; Abigail E Russi
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

Review 3.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

Review 4.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

5.  Neuroinflammation Induces Neurodegeneration.

Authors:  D Kempuraj; R Thangavel; P A Natteru; G P Selvakumar; D Saeed; H Zahoor; S Zaheer; S S Iyer; A Zaheer
Journal:  J Neurol Neurosurg Spine       Date:  2016-11-18

Review 6.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

Review 7.  Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Authors:  Malik R Seals; Monica M Moran; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

8.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.

Authors:  Abigail E Russi; Mark E Ebel; Yuchen Yang; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

Review 9.  Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.

Authors:  M J Mansilla; S Presas-Rodríguez; A Teniente-Serra; I González-Larreategui; B Quirant-Sánchez; F Fondelli; N Djedovic; D Iwaszkiewicz-Grześ; K Chwojnicki; Đ Miljković; P Trzonkowski; C Ramo-Tello; E M Martínez-Cáceres
Journal:  Cell Mol Immunol       Date:  2021-05-06       Impact factor: 22.096

Review 10.  Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases.

Authors:  Subhashini Brahadeeswaran; Narmadhaa Sivagurunathan; Latchoumycandane Calivarathan
Journal:  Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.